Back

Correct risk, correct treatment: insights from SANTORINI

29 August 2026 (12:35 - 12:43)
Organised by: Logo
Congress Presentation Part of: Transforming low-density lipoprotein cholesterol care: from correct risk assessment to combination therapies Cardiovascular Risk Assessment Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor L. Tokgozoglu (Ankara, TR)
Slides
Presentation thumbnail
Evidence from outcome trials: low-density lipoprotein cholesterol reduction and cardiovascular benefit
Doctor J. Brandts (Frankfurt, DE)
Slides
Presentation thumbnail
From trial evidence to real-world practice: efficacy, safety profiles and risk reduction
Professor J. Jukema (Leiden, NL)
Slides
Presentation thumbnail
Oral combination therapy: closing the low-density lipoprotein cholesterol gap
Professor L. Masana (Reus, ES)
Slides
Presentation thumbnail
Q&A
Slides

Access the full session

Session thumbnail
Transforming low-density lipoprotein cholesterol care: from correct risk assessment to combination therapies
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 12:35 CET
You may be interested in
thumbnail
Congress Presentation
Treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe: baseline demographics from the multinational observational SANTORINI study
27 August 2021
thumbnail
Congress Session
How to improve AF understanding and management? Focus on STEER-AF, AFFECT-EU & AFNET
16 April 2023
thumbnail
Congress Presentation
Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study
30 August 2024
thumbnail
Congress Presentation
Simulation of bempedoic acid in the lipid-lowering treatment pathway using the European contemporary SANTORINI cohort of high- and very high-risk patients
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources